~$1 NASDAQ Stocks FNGR, EPOW, PRSO, CYAB, to Watch Now
https://thestreetreports.com/1-nasdaq-stocks-...watch-now/
Investors searching for emerging-growth opportunities near the $0.50 level are watching a group of NASDAQ-listed companies with catalysts spanning AI data centers, high-performance computing, military drones, Edge AI, cybersecurity, battery materials and medical diagnostics. FingerMotion, Inc. (NASDAQ: FNGR), E-Power Inc. (NASDAQ: EPOW), Peraso Inc. (NASDAQ: PRSO), Cyabra, Inc. (NASDAQ: CYAB), and Bluejay Diagnostics, Inc. (NASDAQ: BJDX) each have developments that could keep them in focus among microcap and small-cap investors.
FingerMotion (NASDAQ: FNGR): AI and HPC Infrastructure Strategy
FingerMotion, Inc. (NASDAQ: FNGR) has outlined a strategic plan developed by new management with BlueFlare Energy Solutions Inc. to pursue behind-the-meter Artificial Intelligence (AI) and High-Performance Computing (HPC) infrastructure in North America. The strategy centers on modular, on-site natural-gas generation designed to reduce dependence on lengthy utility interconnection queues while matching infrastructure deployment with contracted enterprise demand. The initiative follows FingerMotion’s August 17 acquisition of a 9.9% equity interest in Lyken AI Computing Inc., further expanding the company’s exposure to the rapidly growing AI infrastructure market.
E-Power (NASDAQ: EPOW): $51.1 Million Contract and AI Data Center Exposure
E-Power Inc. (NASDAQ: EPOW), a provider of AI Data Center (AIDC) microgrid solutions and advanced battery materials, announced that indirectly wholly owned subsidiary Shandong Sunrise Technology Co., Ltd. was awarded and entered into a turnkey equipment and technology-services contract valued at approximately RMB 343.5 million, or US$51.1 million, with Shandong Fusion New Material Co., Ltd. E-Power also operates in graphite anode materials used in lithium-ion batteries, giving the company exposure to both expanding AI data-center power infrastructure and advanced battery-material markets.
Peraso (NASDAQ: PRSO): Military Drones, Defense and Edge AI
Peraso Inc. (NASDAQ: PRSO) is emerging as a potential microcap turnaround opportunity as it expands its proprietary 60GHz mmWave technology into military drones, defense communications, Edge AI, robotics and autonomous systems, supported by its new jam-resistant PRM2145 module. Ladenburg Thalmann recently maintained its Buy rating and increased its 12-month price target to $3.25 from $2.75, while forecasting approximately $17.5 million in 2027 revenue, nearly 200% above its revised 2026 estimate if anticipated growth materializes. With PRSO recently consolidating around the $0.65 range, continued short-selling activity, expanding military/UAV opportunities and the stock’s history of sharp breakouts could keep PRSO on watch for renewed volatility if commercial momentum and buying volume strengthen.
Cyabra (NASDAQ: CYAB): AI National Security and Enterprise Expansion
Cyabra, Inc. (NASDAQ: CYAB) continues expanding adoption of its AI-powered platform designed to detect coordinated online manipulation and protect digital trust. The company announced agreements with two European national-security government agencies to provide real-time detection, analysis and threat intelligence targeting foreign information manipulation, coordinated bot networks and GenAI-amplified narrative threats. Cyabra has also secured an annual contract with a leading interactive-entertainment company to protect its brand and player community from coordinated manipulation and inauthentic activity, demonstrating growing demand for the company’s technology across both government and private-sector markets.
Bluejay Diagnostics (NASDAQ: BJDX): $9.6 Million Cash Position and 750-Patient Study
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) reported approximately $9.6 million in cash and cash equivalents as of June 30, 2026, up from approximately $5.2 million at year-end 2025, supported by approximately $7.6 million in net proceeds from its June private placement. Operationally, Bluejay is advancing toward potential commercialization after signing a U.S. manufacturing contract intended to reduce supply-chain risk, while its SYMON-II pivotal clinical study completed targeted enrollment of 750 patients, providing another important milestone for investors monitoring the company’s diagnostic platform.
Company Summaries
FingerMotion (NASDAQ: FNGR) — Expanding into behind-the-meter AI and HPC infrastructure through a modular power strategy and its investment in Lyken AI Computing.
E-Power (NASDAQ: EPOW) — Building exposure to AI data-center microgrids and advanced battery materials, highlighted by a recently announced approximately $51.1 million contract.
Peraso (NASDAQ: PRSO) — Developing 60GHz mmWave technology for military drones, defense, Edge AI, robotics and autonomous systems, with Ladenburg Thalmann recently raising its price target to $3.25.
Cyabra (NASDAQ: CYAB) — Using proprietary AI-powered threat intelligence to combat coordinated digital manipulation across national-security agencies and major enterprises.
Bluejay Diagnostics (NASDAQ: BJDX) — Advancing toward commercialization with approximately $9.6 million in cash, U.S. manufacturing capabilities and completion of targeted enrollment in its 750-patient SYMON-II pivotal study.
https://thestreetreports.com/1-nasdaq-stocks-...watch-now/
Investors searching for emerging-growth opportunities near the $0.50 level are watching a group of NASDAQ-listed companies with catalysts spanning AI data centers, high-performance computing, military drones, Edge AI, cybersecurity, battery materials and medical diagnostics. FingerMotion, Inc. (NASDAQ: FNGR), E-Power Inc. (NASDAQ: EPOW), Peraso Inc. (NASDAQ: PRSO), Cyabra, Inc. (NASDAQ: CYAB), and Bluejay Diagnostics, Inc. (NASDAQ: BJDX) each have developments that could keep them in focus among microcap and small-cap investors.
FingerMotion (NASDAQ: FNGR): AI and HPC Infrastructure Strategy
FingerMotion, Inc. (NASDAQ: FNGR) has outlined a strategic plan developed by new management with BlueFlare Energy Solutions Inc. to pursue behind-the-meter Artificial Intelligence (AI) and High-Performance Computing (HPC) infrastructure in North America. The strategy centers on modular, on-site natural-gas generation designed to reduce dependence on lengthy utility interconnection queues while matching infrastructure deployment with contracted enterprise demand. The initiative follows FingerMotion’s August 17 acquisition of a 9.9% equity interest in Lyken AI Computing Inc., further expanding the company’s exposure to the rapidly growing AI infrastructure market.
E-Power (NASDAQ: EPOW): $51.1 Million Contract and AI Data Center Exposure
E-Power Inc. (NASDAQ: EPOW), a provider of AI Data Center (AIDC) microgrid solutions and advanced battery materials, announced that indirectly wholly owned subsidiary Shandong Sunrise Technology Co., Ltd. was awarded and entered into a turnkey equipment and technology-services contract valued at approximately RMB 343.5 million, or US$51.1 million, with Shandong Fusion New Material Co., Ltd. E-Power also operates in graphite anode materials used in lithium-ion batteries, giving the company exposure to both expanding AI data-center power infrastructure and advanced battery-material markets.
Peraso (NASDAQ: PRSO): Military Drones, Defense and Edge AI
Peraso Inc. (NASDAQ: PRSO) is emerging as a potential microcap turnaround opportunity as it expands its proprietary 60GHz mmWave technology into military drones, defense communications, Edge AI, robotics and autonomous systems, supported by its new jam-resistant PRM2145 module. Ladenburg Thalmann recently maintained its Buy rating and increased its 12-month price target to $3.25 from $2.75, while forecasting approximately $17.5 million in 2027 revenue, nearly 200% above its revised 2026 estimate if anticipated growth materializes. With PRSO recently consolidating around the $0.65 range, continued short-selling activity, expanding military/UAV opportunities and the stock’s history of sharp breakouts could keep PRSO on watch for renewed volatility if commercial momentum and buying volume strengthen.
Cyabra (NASDAQ: CYAB): AI National Security and Enterprise Expansion
Cyabra, Inc. (NASDAQ: CYAB) continues expanding adoption of its AI-powered platform designed to detect coordinated online manipulation and protect digital trust. The company announced agreements with two European national-security government agencies to provide real-time detection, analysis and threat intelligence targeting foreign information manipulation, coordinated bot networks and GenAI-amplified narrative threats. Cyabra has also secured an annual contract with a leading interactive-entertainment company to protect its brand and player community from coordinated manipulation and inauthentic activity, demonstrating growing demand for the company’s technology across both government and private-sector markets.
Bluejay Diagnostics (NASDAQ: BJDX): $9.6 Million Cash Position and 750-Patient Study
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) reported approximately $9.6 million in cash and cash equivalents as of June 30, 2026, up from approximately $5.2 million at year-end 2025, supported by approximately $7.6 million in net proceeds from its June private placement. Operationally, Bluejay is advancing toward potential commercialization after signing a U.S. manufacturing contract intended to reduce supply-chain risk, while its SYMON-II pivotal clinical study completed targeted enrollment of 750 patients, providing another important milestone for investors monitoring the company’s diagnostic platform.
Company Summaries
FingerMotion (NASDAQ: FNGR) — Expanding into behind-the-meter AI and HPC infrastructure through a modular power strategy and its investment in Lyken AI Computing.
E-Power (NASDAQ: EPOW) — Building exposure to AI data-center microgrids and advanced battery materials, highlighted by a recently announced approximately $51.1 million contract.
Peraso (NASDAQ: PRSO) — Developing 60GHz mmWave technology for military drones, defense, Edge AI, robotics and autonomous systems, with Ladenburg Thalmann recently raising its price target to $3.25.
Cyabra (NASDAQ: CYAB) — Using proprietary AI-powered threat intelligence to combat coordinated digital manipulation across national-security agencies and major enterprises.
Bluejay Diagnostics (NASDAQ: BJDX) — Advancing toward commercialization with approximately $9.6 million in cash, U.S. manufacturing capabilities and completion of targeted enrollment in its 750-patient SYMON-II pivotal study.
